146 related articles for article (PubMed ID: 20875375)
1. N-Acetyltransferase-2 (NAT2) genotype frequency among Jordanian volunteers.
Jarrar YB; Ismail S; Irshaid YM
Int J Clin Pharmacol Ther; 2010 Oct; 48(10):688-94. PubMed ID: 20875375
[TBL] [Abstract][Full Text] [Related]
2. N-acetyltransferase-2 genotypes among patients with rheumatoid arthritis attending Jordan University Hospital.
Oqal MK; Mustafa KN; Irshaid YM
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1007-10. PubMed ID: 22731637
[TBL] [Abstract][Full Text] [Related]
3. N-acetyltransferase-2 genotypes among Jordanian patients with diabetes mellitus.
Irshaid YM; Abujbara MA; Ajlouni KM; El-Khateeb M; Jarrar YB
Int J Clin Pharmacol Ther; 2013 Jul; 51(7):593-9. PubMed ID: 23587153
[TBL] [Abstract][Full Text] [Related]
4. Arylamine N-acetyltransferase-2 genotypes in the Thai population.
Kukongviriyapan V; Prawan A; Tassaneyakul W; Aiemsa-Ard J; Warasiha B
Br J Clin Pharmacol; 2003 Mar; 55(3):278-81. PubMed ID: 12630978
[TBL] [Abstract][Full Text] [Related]
5. Polymorphic N-acetyltransferase (NAT2) genotyping of Emiratis.
Woolhouse NM; Qureshi MM; Bastaki SM; Patel M; Abdulrazzaq Y; Bayoumi RA
Pharmacogenetics; 1997 Feb; 7(1):73-82. PubMed ID: 9110365
[TBL] [Abstract][Full Text] [Related]
6. Sequence analysis of the N-acetyltransferase 2 gene (NAT2) among Jordanian volunteers.
Jarrar YB; Balasmeh AA; Jarrar W
Libyan J Med; 2018 Dec; 13(1):1408381. PubMed ID: 29173142
[TBL] [Abstract][Full Text] [Related]
7. Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals.
Bakayev VV; Mohammadi F; Bahadori M; Sheikholslami M; Javeri A; Masjedi MR; Velayati AA
Eur J Clin Pharmacol; 2004 Sep; 60(7):467-71. PubMed ID: 15316701
[TBL] [Abstract][Full Text] [Related]
8. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.
Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki S
Ann Hum Genet; 2017 Sep; 81(5):190-196. PubMed ID: 28653770
[TBL] [Abstract][Full Text] [Related]
9. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
10. NAT2 gene polymorphism as a possible marker for susceptibility to bladder cancer in Japanese.
Inatomi H; Katoh T; Kawamoto T; Matsumoto T
Int J Urol; 1999 Sep; 6(9):446-54. PubMed ID: 10510890
[TBL] [Abstract][Full Text] [Related]
11. Arylamine N-acetyltransferase (NAT2) genotypes in a Turkish population.
Aynacioglu AS; Cascorbi I; Mrozikiewicz PM; Roots I
Pharmacogenetics; 1997 Aug; 7(4):327-31. PubMed ID: 9295061
[TBL] [Abstract][Full Text] [Related]
12. N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men.
Hamasaki T; Inatomi H; Katoh T; Aono H; Ikuyama T; Muratani T; Matsumoto T
Int J Urol; 2003 Mar; 10(3):167-73. PubMed ID: 12622714
[TBL] [Abstract][Full Text] [Related]
13. NAT2*7 allele is a potential risk factor for adult brain tumors in Taiwanese population.
Liu HE; Hsiao PY; Lee CC; Lee JA; Chen HY
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):661-5. PubMed ID: 18349284
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic sclerosis.
Skretkowicz K; Skretkowicz J; Gawrońska-Szklarz B; Górnik W; Rychlik-Sych M; Sysa-Jedrzejowska A
Eur J Clin Pharmacol; 2005 Jan; 60(11):773-8. PubMed ID: 15565348
[TBL] [Abstract][Full Text] [Related]
15. Arylamine N-acetyltransferase (NAT2) genotypes in Africans: the identification of a new allele with nucleotide changes 481C>T and 590G>A.
Dandara C; Masimirembwa CM; Magimba A; Kaaya S; Sayi J; Sommers DK; Snyman JR; Hasler JA
Pharmacogenetics; 2003 Jan; 13(1):55-8. PubMed ID: 12544513
[TBL] [Abstract][Full Text] [Related]
16. Genotyping of the arylamine N-acetyltransferase polymorphism in the prediction of idiosyncratic reactions to trimethoprim-sulfamethoxazole in infants.
Zielińska E; Niewiarowski W; Bodalski J; Rebowski G; Skretkowicz J; Mianowska K; Sekulska M
Pharm World Sci; 1998 Jun; 20(3):123-30. PubMed ID: 9618736
[TBL] [Abstract][Full Text] [Related]
17. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans.
Bell DA; Taylor JA; Butler MA; Stephens EA; Wiest J; Brubaker LH; Kadlubar FF; Lucier GW
Carcinogenesis; 1993 Aug; 14(8):1689-92. PubMed ID: 8102597
[TBL] [Abstract][Full Text] [Related]
18. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles.
Ferguson RJ; Doll MA; Rustan TD; Gray K; Hein DW
Drug Metab Dispos; 1994; 22(3):371-6. PubMed ID: 7915226
[TBL] [Abstract][Full Text] [Related]
19. Genotype and allele frequencies of N-acetyltransferase 2 and glutathione S-transferase in the Iranian population.
Torkaman-Boutorabi A; Hoormand M; Naghdi N; Bakhshayesh M; Milanian I
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1207-11. PubMed ID: 17880378
[TBL] [Abstract][Full Text] [Related]
20. N-acetyltransferase polymorphism among northern Sudanese.
Al-Yahyaee S; Gaffar U; Al-Ameri MM; Qureshi M; Zadjali F; Ali BH; Bayoumi R
Hum Biol; 2007 Aug; 79(4):445-52. PubMed ID: 18075007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]